Healthcare
M&A Advisory
Pharmaceutical
M&A Advisory
Lazard
Full Credential Description
Anadys Pharmaceuticals. United States. Announced Date 26/05/2010. Closed Date 01/06/2010. Deal value: $13m. Registered direct offering of common stock. Industry: Anadys Pharmaceuticals is a biopharmaceutical company focused on developing novel medicines for the treatment of hepatitis and cancer.